<DOC>
	<DOCNO>NCT01564576</DOCNO>
	<brief_summary>The aim present study prospectively ass whether deep neuromuscular blockade ( NMB ) ( zero response train four post tetanic count 10 response use nerve stimulator monitoring ) end surgery , follow sugammadex ( bridion® ) reversal superior present practice gradual NMB reduction end surgery follow neostigmine ( Prostigmin® , Vagostigmin® ) reversal , patient undergo laparoscopic sleeve gastrectomy . The investigator hypothesize provide deep NMB throughout procedure create good condition surgery , reversal deep NMBwith sugammadex ( bridion® ) enable quick full reversal relaxation few postoperative respiratory event compare neostigmine ( Prostigmin® , Vagostigmin® ) reversal . Participants follow duration hospital stay , expect average 7 day .</brief_summary>
	<brief_title>Neuromuscular Blockade Surgical Conditions</brief_title>
	<detailed_description>In laparoscopic bariatric procedure , CO2 use insufflate peritoneal cavity increase intra-abdominal pressure optimal exposure suitable operating field . However , increase intra-abdominal pressure pneumoperitoneum profound physiological effect include reduction urine output , portal venous flow , respiratory compliance , cardiac output . Abdominal muscle relaxation change abdominal wall compliance , produce use anesthetic muscle relaxant , important contributor achievement optimal surgical field use minimal abdominal pressure . A practical dilemma maintain good surgical condition till end operative procedure deep anesthesia muscle relaxation one hand , awake spontaneously breathe patient end surgery . Reversal agent often used ensure reversal nondepolarizing neuromuscular blockade ( NMB ) . The widely use acetylcholinesterase inhibitor neostigmine ( Prostigmin® , Vagostigmin® ) . However , neostigmine partially effective NMB deep ( le 1 response use train four monitoring ) may also associate adverse effect , cholinergic cardiovascular gastrointestinal events.Sugammadex ( bridion® ) modify gamma cyclodextrin specifically design reversal NMB induce aminosteroid muscle relaxant include rocuronium bromide ( Zemuron® , Esmeron® ) . Sugammadex ( bridion® ) act encapsulate unbound rocuronium bromide ( Zemuron® , Esmeron® ) molecules reduce concentration neuromuscular junction.Studies surgical patient show sugammadex ( bridion® ) rapidly safely revers rocuronium bromide ( Zemuron® , Esmeron® ) induce NMB . Unlike acetylcholinesterase inhibitor , sugammadex ( bridion® ) also effective reversal deep NMB ( response train four monitor even response post tetanic count monitoring ) . Laparoscopic weight reduction surgery require appropriate use muscle relaxation ; however , uncertainty remain include indeterminate dose unpredictable effect . Additionally , time recovery train four ( TOF ) ratio 0.9 obese [ 25.9 ( 6.7 , 13.5-41.0 ) min ] overweight group [ 14.6 ( 7.7 , 3.3-28.5 ) min ] significantly long normal weight group [ 6.9 ( 2.0 , 3.0-10.7 ) min ] . Therefore , obese patient increase risk residual muscle relaxation follow surgery . Sugammadex ( bridion® ) recently find reach peak effect faster neostigmine ( Prostigmin® , Vagostigmin® ) , obese patient . In study , time TOFR ≥ 0.9 13 min 50 μg/kg neostigmine ( Prostigmin® , Vagostigmin® ) 1.7 min 2 mg/kg sugammadex . Therefore , appear sugammadex ( bridion® ) may predictably prevent occurrence residual muscle relaxation compare neostigmine ( Prostigmin® , Vagostigmin® ) . The aim present study prospectively ass whether deep NMB ( zero response train four post tetanic count 10 response use nerve stimulator monitoring ) till end surgery , follow sugammadex ( bridion® ) reversal superior present practice gradual NMB reduction end surgery follow neostigmine ( Prostigmin® , Vagostigmin® ) reversal , patient undergo laparoscopic sleeve gastrectomy . The investigator hypothesize provide deep NMB throughout procedure create good condition surgery , reversal deep muscle relaxation sugammadex ( bridion® ) enable quick full reversal relaxation few postoperative respiratory event compare neostigmine ( Prostigmin® , Vagostigmin® ) reversal . Surgical condition assess surgeon , blind treatment give patient , 1-4 Likert scale 5 minute interval abdominal insufflation gas till end surgery ( estimate time 120 minute ) . Participants follow respiratory adverse event admission post anesthesia care unit discharge surgical department ( continuous measurement hemoglobin oxygen saturation respiratory rate expect average 3 hour ) admission surgical department till time home discharge ( measurement hemoglobin oxygen saturation respiratory rate every 6 hour expect average 5 day ) .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>American Society Anesthesiologists physical status Class IIII , schedule undergo elective sleeve gastrectomy Neuromuscular disorder affect NMB history malignant hyperthermia significant renal dysfunction allergy medication use general anesthesia concurrent use medication know interfere NMBAs sugammadex ( antibiotic , anticonvulsant , magnesium salt ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Laparoscopic surgery</keyword>
	<keyword>Anesthesiology</keyword>
	<keyword>Neuromuscular blockade</keyword>
</DOC>